# Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

> **NCT00880750** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 72 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Lanthanum carbonate Granule Formulation
- **DRUG:** Lanthanum carbonate Chewable Tablets (Fosrenol)

## Key facts

- **NCT ID:** NCT00880750
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-28
- **Primary completion:** 2009-06-22
- **Final completion:** 2009-06-22
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880750, "Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00880750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*